Research participants undergo careful evaluation by study physicians and are closely followed by the medical staff.
All our enrolling studies have been conducted on humans and are safe before potential research participants become involved. There is never a charge to the participant or insurance as the cost of medical research is paid for by the pharmaceutical company that sponsors the research program.
Age: 21-70
Condition: Overweight patients with a BMI of 30-45 who will be provided tirzepatide to lose 15% of your body weight. To follow, an upper GI endoscopy with a groundbreaking procedure called a DMR to see if it will help maintain your weight loss. (Can not be Diabetic)
Age: 18-75
Condition: Uncontrolled, Type 2 Diabetics currently using Semaglutide or Tirzepatide for at least 3 months. A1c 7.5-10.5.
Age: 4-30
Condition: Type 1 or Type 2 Diabetics that use a self monitoring glucose device to manage their Diabetes.
Age: 18 or older
Condition: IBS/Diarrhea with pain or cramping most days
Age: 18-49
Condition: Endometriosis with Moderate to Severe pain in premenopausal women9
Investigators Research Group, LLC | 321 E. Northfield Drive, Suite 100 Brownsburg, Indiana 46112 | [email protected]